Inventor · disambiguated record
Peter Schulz-Knappe
Also filed as: SCHULZ-KNAPPE PETER
13 granted patents·11 pending applications·90 citations·filing 1994–2020
88Inventor score
Files withPROTAGEN AG8ONCIMMUNE GERMANY GMBH4FORSSMANN WOLF GEORG3ELECTROPHORETICS LTD2WOLF GEORG FORSSMANN2
Top patents by PatentIndex Score
24 records- 0177US5744444AHPTH-fragment-(1-37), the preparation thereof, medicaments containing same and the use thereofHAEMOPEP PHARMA GMBH·Filed 1995·Granted Apr 28, 1998·35 cites·6 claims
- 0262US10976321B2Mass spectrometric quantitationELECTROPHORETICS LTD·Filed 2017·Granted Apr 13, 2021·0 cites·19 claims
- 0362US5891904AUse of inhibitors of phosphodiesterase IVFORSSMANN WOLF GEORG·Filed 1997·Granted Apr 6, 1999·26 cites·15 claims
- 0461US11609237B2Marker sequences for diagnosing and stratifying systemic sclerosis patientsONCIMMUNE GERMANY GMBH·Filed 2019·Granted Mar 21, 2023·0 cites·11 claims
- 0561US2005106678A1Human circulating cytokine CC-1WOLF GEORG FORSSMANN·Filed 2004·Application pending·0 cites
- 0655US11860162B2Marker sequences for diagnosing and stratifying SLE patientsONCIMMUNE GERMANY GMBH·Filed 2020·Granted Jan 2, 2024·0 cites·9 claims
- 0755US2008234187A1Human circulating cytokine CC-1WOLF GEORG FORSSMANN·Filed 2006·Application pending·0 cites
- 0852US6180773B1Tandem cDNAs encoding chemokines CC-1, CC-2, and CC-3FORSSMANN WOLF GEORG·Filed 1997·Granted Jan 30, 2001·9 cites·15 claims
- 0951US10571477B2Marker sequences for diagnosing and stratifying systemic sclerosis patientsPROTAGEN AG·Filed 2015·Granted Feb 25, 2020·0 cites·11 claims
- 1050US11320438B2Isotopic methods for measurement of tryptophan and metabolites thereofELECTROPHORETICS LTD·Filed 2016·Granted May 3, 2022·0 cites·25 claims
- 1150US6875616B1Process for determining the status of an organism by peptide measurementBIOVISION AG·Filed 1997·Granted Apr 5, 2005·14 cites·23 claims
- 1243US10746735B2Marker sequences for diagnosing and stratifying SLE patientsPROTAGEN AG·Filed 2015·Granted Aug 18, 2020·0 cites·4 claims
- 1343US6083483AInhibitors of phosphodiesterase IV for x-ray imagingFORSSMANN WOLF GEORG·Filed 1999·Granted Jul 4, 2000·6 cites·12 claims
- 1442US9470692B2Mass spectrometric analysisBAUMANN CHRISTIAN·Filed 2009·Granted Oct 18, 2016·0 cites·37 claims
- 1539US2015293120A1Marker sequences for rheumatoid arthritisPROTAGEN AG·Filed 2013·Application pending·0 cites
- 1637US2021231663A1Melanoma checkpoint inhibitor detection and treatmentONCIMMUNE GERMANY GMBH·Filed 2018·Application pending·0 cites
- 1736US2015323529A1Marker sequences for neuromyelitis optica (nmo) and use thereofPROTAGEN AG·Filed 2013·Application pending·0 cites
- 1836US2020150117A1Immuno-oncology for the treatment of cancerONCIMMUNE GERMANY GMBH·Filed 2018·Application pending·0 cites
- 1935US2019128884A1Marker sequences for managing the therapy of rheumatoid arthritis patientsPROTAGEN AG·Filed 2017·Application pending·0 cites
- 2035US2014371095A1Novel method for identifying specific marker sequences for prostate cancerPROTAGEN AG·Filed 2012·Application pending·0 cites
- 2132US10060911B2Method for diagnosis of high-affinity binders and marker sequencesMUELLNER STEFAN·Filed 2012·Granted Aug 28, 2018·0 cites·15 claims
- 2232US2019120834A1Marker sequences for rheumatoid arthritisPROTAGEN AG·Filed 2017·Application pending·0 cites
- 2329US2003105293A1Human circulating cytokine cc-1Filed 1994·Application pending·0 cites
- 2426US2015177247A1Method for identifying marker sequences for gynaecological malignant tumoursPROTAGEN AG·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →